It is suggested in a study that DIA4 was downregulated in drug‐resistant ovarian cancer tissues relative to the sensitive ones, and inhibited PDIA4 predicted shorter disease‐free survival and overall survival in both the tested surgical specimens and the TCGA cohort.17 This evidence concerns the gene PDIA4 and ovarian carcinoma.